Solving EPHX2 and Polyunsaturated Fatty Acid Interactions in Anorexia Nervosa

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study uses a meal-challenge protocol to assess if patients with anorexia nervosa show a differential metabolism in response to food in comparison to healthy controls. This study determines how heritable and biochemical factors influence food metabolism in anorexia nervosa in order to develop more effective treatment strategies.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 55
Healthy Volunteers: t
View:

• Ill AN subjects will meet current Diagnostic and Statistical Manual of Mental Disorders (DSM V) diagnosis of AN, body mass index (BMI) between 11 kg/m² and 17.5 kg/m², or BMI \> 17.5 kg/m² with active eating disorder symptoms.

• Recovered AN must meet the following criteria at time of study entry: 1) Current or past DSM V diagnosis of AN; 2) BMI between 18.5 kg/m2 and 30 kg/m2; 3) Having maintained a BMI of \>18.5 for at least one year.

• Control must be healthy adolescent or woman negative on our screen for AN, other Axis I psychiatric illnesses, and having maintained a BMI of between 18.5-30 kg/m² since the age of 18.

Locations
United States
California
UC San Diego Altman Clinical and Translational Research Institute
RECRUITING
La Jolla
Other Locations
Canada
Program for Eating Disorders, Toronto General Hospital
RECRUITING
Toronto
Contact Information
Primary
Pei-an (Betty) Shih, MPM, PhD
eatingdisorderresearch@ucsd.edu
(858) 534-0828
Backup
Nhien Nguyen, MS
n7nguyen@ucsd.edu
Time Frame
Start Date: 2016-11-10
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 300
Treatments
Other: Anorexia nervosa I
Anorexia nervosa with BMI \<=17.5 kg/m² or BMI \>17.5 kg/m² with regular binge-purge episodes
Other: Anorexia nervosa II
Anorexia nervosa with BMI \> 18.5 kg/m² for at least 12 months.
Other: Controls
Healthy control women
Related Therapeutic Areas
Sponsors
Collaborators: University of Toronto, University of California, Davis
Leads: University of California, San Diego

This content was sourced from clinicaltrials.gov